Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma

NICE technology appraisals [TA269] Published date:

NICE recommends vemurafenib as a possible treatment for unresectable or metastatic melanoma with the BRAF V600 mutation.

Get involved